Home » Stocks » TWST

Twist Bioscience Corporation (TWST)

Stock Price: $117.34 USD -4.14 (-3.41%)
Updated Jul 23, 2021 4:00 PM EDT - Market closed
After-hours: $117.03 -0.31 (-0.26%) Jul 23, 7:34 PM
Market Cap 5.74B
Revenue (ttm) 113.00M
Net Income (ttm) -123.34M
Shares Out 48.71M
EPS (ttm) -2.72
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 23
Last Price $117.34
Previous Close $121.48
Change ($) -4.14
Change (%) -3.41%
Day's Open 121.40
Day's Range 116.50 - 121.63
Day's Volume 296,614
52-Week Range 53.81 - 214.07

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Twist Bioscience Corporation (NASDAQ: TWST) has acquired iGenomX, a developer of multiplex library preparation tools for next-generation sequencing workflows, for $35 million.   Twist said the acquisiti...

3 weeks ago - Benzinga

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon pl...

3 weeks ago - Business Wire

SCOTTS VALLEY, Calif., June 16, 2021 /PRNewswire/ -- Dovetail Genomics, the industry leader in advanced proximity ligation genomic solutions, today announced availability of its new line of capture Hi-C...

1 month ago - PRNewsWire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon pl...

Other stocks mentioned: REGN
1 month ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon pl...

1 month ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--The DNA Data Storage Alliance, an organization of more than 25 leading companies formed by Twist Bioscience Corporation (NASDAQ: TWST), Illumina, Inc. (NASD...

Other stocks mentioned: ILMN, WDC
1 month ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon pl...

1 month ago - Business Wire

Incredible scientific advances could reward investors -- if they have the patience.

Other stocks mentioned: PACB
1 month ago - The Motley Fool

They're well below peak levels set earlier this year. But they could be huge winners over the long run.

Other stocks mentioned: CRSP, EXAS, TDOC
1 month ago - The Motley Fool

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST) today launched the Twist Library Preparation Enzymatic Fragmentation Kit 2.0, a robust all-in-one solution desig...

2 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon pl...

2 months ago - Business Wire

Female entrepreneurs are disrupting the traditionally male-dominated field of bioscience. One such disruptor is Dr. Emily Leproust, CEO and co-founder of Twist Bioscience (TWST), whose pioneering work o...

2 months ago - ETF Trends

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon pl...

2 months ago - Business Wire

One especially stands out.

2 months ago - The Motley Fool

Twist Bioscience (TWST) delivered earnings and revenue surprises of -2.63% and 12.56%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon pl...

2 months ago - Business Wire

Twist Bioscience brings to mind another genomic revolution pioneer.

Other stocks mentioned: ARKG, ILMN
2 months ago - The Motley Fool

Twist Bioscience (TWST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Investors will focus on the top-line and bottom-line numbers when Twist (TWST) reports fiscal second-quarter 2021 results.

2 months ago - Zacks Investment Research

SOUTH SAN FRANCISCO, Calif. & FRANKFURT--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using it...

2 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon pl...

3 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon pl...

3 months ago - Business Wire

And they all have one key thing in common.

Other stocks mentioned: REGN, VRTX, TDOC
3 months ago - The Motley Fool

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon pl...

3 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, toda...

3 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif & BEIJING--(BUSINESS WIRE)--AcornMed Biotechnology Co., Ltd. (AcornMed), a precision medicine organization that specializes in the testing and analysis of solid and blood tumo...

3 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon pl...

3 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, is p...

3 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif. & LA JOLLA, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA u...

4 months ago - Business Wire

These biotech companies are small, but they have tremendous growth prospects.

Other stocks mentioned: FATE
4 months ago - The Motley Fool

SOUTH SAN FRANCISCO, Calif. & NEW YORK--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its...

4 months ago - Business Wire

Sure, the ARK Invest CIO likes Tesla, but there are other stocks you might not know about.

Other stocks mentioned: TRMB
4 months ago - The Motley Fool

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon pl...

4 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist began shipping its new synthetic RNA reference controls, including B.1.351 and P.1, that have emerged in South Africa and Brazil, respectively.

4 months ago - Business Wire

Twist Biosciences (TWST) is a biology company developing a breakthrough synthetic DNA technology that has the potential to change the world. The post A Golden Buying Opportunity Amid the Recent Tech Sec...

4 months ago - InvestorPlace

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

4 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif. & BOULDER, Colo.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic ...

4 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

4 months ago - Business Wire

Twist Bioscience Corp (NASDAQ: TWST) has launched its NGS Methylation Detection System, end-to-end sample preparation, and target enrichment solution for identifying methylated regions in the human geno...

5 months ago - Benzinga

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

5 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

5 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

5 months ago - Business Wire

Twist Bioscience Corp (NASDAQ: TWST) and Victorian Clinical Genetic Services (VCGS) have developed a novel whole-exome capture assay, which utilizes Next Generation Sequencing to conduct analysis and se...

5 months ago - Benzinga

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

5 months ago - Business Wire

An analyst downgraded the stock despite its better-than-expected quarterly results.

5 months ago - The Motley Fool

Twist Bioscience (TWST) delivered earnings and revenue surprises of 2.70% and 11.47%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Shares of Twist Bioscience (NASDAQ:TWST) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 28.00% over the past year to ($0.72), which...

5 months ago - Benzinga

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

5 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

5 months ago - Business Wire

Twist Bioscience (TWST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

About TWST

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with ImmunoPrecise Antibodies Ltd.; Victorian Clinical Genetic Services; Vivlion GmbH; an... [Read more...]

Industry
Diagnostics & Research
IPO Date
Oct 31, 2018
CEO
Emily Leproust
Employees
525
Stock Exchange
NASDAQ
Ticker Symbol
TWST
Full Company Profile

Financial Performance

In 2020, TWST's revenue was $90.10 million, an increase of 65.67% compared to the previous year's $54.39 million. Losses were -$139.93 million, 30.0% more than in 2019.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for TWST stock is "Buy." The 12-month stock price forecast is 124.29, which is an increase of 5.92% from the latest price.

Price Target
$124.29
(5.92% upside)
Analyst Consensus: Buy